87379725 - EPIMMUNE

Information

  • Trademark
  • 87379725
  • Serial Number
    87379725
  • Filing Date
    March 21, 2017
    7 years ago
  • Transaction Date
    December 07, 2020
    4 years ago
  • Status Date
    December 07, 2020
    4 years ago
  • Published for Opposition Date
    March 06, 2018
    6 years ago
  • Location Date
    May 07, 2020
    4 years ago
  • Status Code
    606
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    NELMAN, JESSE M
  • Attorney Docket Number
    2473.0930000
    Attorney Name
    Monica Riva Talley
    Law Office Assigned Location Code
    M40
  • Owners
Mark Drawing Code
4000
Mark Identification
EPIMMUNE
Case File Statements
  • GS0011: Peptides for industrial purpose for analyzing and detecting certain cytokines, biomarkers, and toxins for laboratory or research use; reagents for scientific or medical research use; protein in raw material form for scientific or laboratory purposes; protein raw material form for scientific and medical research; chemical additives for use in the manufacture of food, food preservative compositions, chemical substances for preserving foodstuffs, namely, food preservatives; artificial sweeteners for beverages; biological preparations other than for medical or veterinary purposes for use in cell cultures; stem cells other than for medical or veterinary purposes
  • GS0051: Food for babies except lacteal flour for babies; lacteal flour for babies; pharmaceutical preparations for prevention and treatment of cancer; vaccines; pharmaceutical and veterinary preparations for treatment of central or peripheral nervous system related diseases; pharmaceutical and veterinary preparations for treatment of cancer or tumor disease; pharmaceutical and veterinary preparations for treatment of benign prostatic hyperplasia; preparations for use in making medicated beverages, namely, powdered nutritional and dietary supplement drink mixes, dietary supplements for human consumption; protein dietary supplements; diet capsules; dietary supplements for animals; dietary supplements; nutraceuticals for use as dietary supplements; drug delivery agents in the form of capsules, powders, tablets, or edible wafers that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; pharmaceutical preparations for diagnosis of benign prostatic hyperplasia; vitamin based beverages for medical purposes; functional beverages for relieving and preventing hangovers, namely, electrolyte drinks for medical purposes; amino acid containing beverages, namely, beverages for use as a nutritional supplement; plant extract other than for medical or veterinary purposes for use in the manufacture of dietary supplements; amino acid for use in the manufacture of dietary supplements
  • GS0351: Providing consumer information services in the field of peptide medical products; providing a web site featuring consumer information about peptides in the fields of health and nutrition; providing consumer information about dietary supplements and nutrition in relation to peptides; consumer survey services in the field of cosmetics
  • GS0421: Research and development of vaccines and medicines; Medical research in the field of cancer; Pharmaceutical development; Pharmaceutical research services; Cosmetology research; Cosmetic research; Research and development of DNA chips; Biotechnology research; Advisory services relating to biotechnology; Biological research; Gene analysis for scientific research purposes; Scientific research in the field of genetics; Chemical analysis; Chemistry services, namely, chemistry consultation, research in the field of chemistry, laboratory analysis in the field of chemistry; Research and analysis in the field of chemistry; Chemical research; Computer software development; Computer software research; Design of computer microchips
  • GS0441: Providing medical and healthcare information in the field of peptide medical products; medical skin care services; medical clinic services, namely, microdermabrasion, laser peels, skin care, and facials for prevention or treatment of general or localized inflammatory disease; providing information about dietary supplements and nutrition in relation to peptides; dietary and nutritional guidance; providing information about dietary food supplements for medical purposes in field of anti-inflammatory and anticancer; providing information about medical supplements for treatment of bone, joint, muscle and connective tissue related diseases; dispensing of Korean pharmaceuticals; dental services, namely, dental consultations, dentist services, dental hygienist services, and dental imaging services; health care; hair health care services; cosmetic surgery; medical assistance; scalp care services; beauty salons; make-up application services; beauty consultancy services; obesity consultation services; dental assistant services in the nature of medical assistance, namely, oral medical care services
Case File Event Statements
  • 12/7/2020 - 4 years ago
    43 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6
  • 12/7/2020 - 4 years ago
    42 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6
  • 5/8/2020 - 4 years ago
    41 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 5/7/2020 - 4 years ago
    40 - EXTENSION 4 GRANTED Type: EX4G
  • 4/23/2020 - 4 years ago
    39 - EXTENSION 4 FILED Type: EXT4
  • 5/7/2020 - 4 years ago
    38 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 4/23/2020 - 4 years ago
    37 - TEAS EXTENSION RECEIVED Type: EEXT
  • 11/2/2019 - 5 years ago
    36 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 10/31/2019 - 5 years ago
    35 - EXTENSION 3 GRANTED Type: EX3G
  • 10/31/2019 - 5 years ago
    34 - EXTENSION 3 FILED Type: EXT3
  • 10/31/2019 - 5 years ago
    33 - TEAS EXTENSION RECEIVED Type: EEXT
  • 4/11/2019 - 5 years ago
    32 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 4/9/2019 - 5 years ago
    31 - EXTENSION 2 GRANTED Type: EX2G
  • 4/9/2019 - 5 years ago
    30 - EXTENSION 2 FILED Type: EXT2
  • 4/9/2019 - 5 years ago
    29 - TEAS EXTENSION RECEIVED Type: EEXT
  • 10/23/2018 - 6 years ago
    28 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 10/25/2018 - 6 years ago
    27 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 10/23/2018 - 6 years ago
    26 - EXTENSION 1 GRANTED Type: EX1G
  • 10/23/2018 - 6 years ago
    25 - EXTENSION 1 FILED Type: EXT1
  • 10/23/2018 - 6 years ago
    24 - TEAS EXTENSION RECEIVED Type: EEXT
  • 5/1/2018 - 6 years ago
    23 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 3/6/2018 - 6 years ago
    22 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 3/6/2018 - 6 years ago
    21 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 2/14/2018 - 6 years ago
    20 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 1/28/2018 - 6 years ago
    19 - ASSIGNED TO LIE Type: ALIE
  • 1/18/2018 - 6 years ago
    18 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 1/18/2018 - 6 years ago
    17 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 1/18/2018 - 6 years ago
    16 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 1/18/2018 - 6 years ago
    15 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 1/18/2018 - 6 years ago
    14 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 1/10/2018 - 6 years ago
    13 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 1/10/2018 - 6 years ago
    12 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 1/10/2018 - 6 years ago
    11 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 12/19/2017 - 7 years ago
    10 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 12/19/2017 - 7 years ago
    9 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 12/19/2017 - 7 years ago
    8 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 12/19/2017 - 7 years ago
    7 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 6/20/2017 - 7 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 6/20/2017 - 7 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 6/20/2017 - 7 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 6/14/2017 - 7 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/24/2017 - 7 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 3/24/2017 - 7 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP